Biotech investor sets his sights on fibrosis

Biotech investor Claus Christiansen believes drugs to treat fibrosis will represent a huge market in the near future. His company Nordic Biosciences has discovered a biomarker that can predict the spread of lung fibrosis.

Log in to read our articles

Welcome to MedWatch. A part of our content is exclusive and reserved for our users.

Try us for 14 days

Try a trial subscription for access to our quality journalism

Frontpage right now

Reuters: Kinesere vil købe J&J's diabetesforretning

Amerikanske Johnson & Johnson kan være på vej til at sælge sin forretning for diabetesudstyr for godt 24 mia. kr., efter flere kinesiske aktører ifølge Reuters har vist interesse i at overtage forretningsdelen.

Related articles